However, Smad3 palmitoylation mediated by palmitoyltransferase ZDHHC19 promotes activation of the TGF-β signaling pathway, and its interaction with EP300 promotes expression of mesenchymal markers in the mesenchymal subtype of GBM. Here, ZDHHC19 is linked to glioblastoma.